If a drug that was an inhibitor of PP1 activity was ingested by a person

Glycogen phosphorylase would be de-phosphorylated and inactive.
Glycogen phosphorylase would be de-phosphorylated and retain some activity.
Glycogen phosphorylase would remain phosphorylated and inactive.
Glycogen phosphorylase would remain phosphorylated and retain some activity.